Gene fusions can drive cancer development by creating oncogenes or disrupting tumor suppressor genes. The fusion proteins often have altered functions that promote uncontrolled cell growth, evade apoptosis, or increase metastatic potential. For example, the BCR-ABL fusion gene in chronic myeloid leukemia (CML) results in a constitutively active tyrosine kinase, driving unregulated cell proliferation.
